1-6 of 6
Conrad Russell Young Cruz
Close
Sort by
Journal Articles

Outcome of Donor-Derived Tumor Associated Antigen-Specific T Cell Therapy in Patients with High-Risk or Relapsed Acute Leukemia Post Allogeneic BMT

Hannah Kinoshita, Kenneth R. Cooke, Melanie Grant, Maja Stanojevic, Conrad Russell Young Cruz, Michael Keller, Maria Fernanda Fortiz, Fahmida Hoq, Haili Lang, John Barrett, Hua Liang, Jay Tanna, Nan Zhang, Abeer Shibli, Anushree Datar, Kirsten M. Williams, Hema Dave, Jeffrey Dome, David Jacobsohn, Patrick Hanley, Richard J. Jones, Catherine M. Bollard
Journal: Blood
Blood (2021) 138 (Supplement 1): 2828.
https://doi.org/10.1182/blood-2021-153207
Published: 2021
Journal Articles

Hiv Specific T Cells Generated from HIV Naive Adult and Cord Blood Donors Target a Range of Novel Viral Epitopes: Implications for a Cure Strategy after Allogeneic HSCT and CBT

Shabnum Patel, PhD, Shuroug Albihani, Elizabeth Williams, Julia Sung, Conrad Russell Young Cruz, MD PhD, R. Brad Jones, PhD, Elizabeth J Shpall, MD, David Margolis, Richard F Ambinder, MD, Catherine M. Bollard, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 1010.
https://doi.org/10.1182/blood.V130.Suppl_1.1010.1010
Published: 2017
Journal Articles

Human Papillomavirus (HPV)--Specific T-Cells Can be Generated from Unimmunized Donors for Third Party Cell Therapy of HPV-Associated Neoplasms

Conrad Russell Young Cruz, MD PhD, Sarah McCormack, BA, Kaylor Elizabeth Wright, BS, Allison B Powell, BS, Haili Lang, MS, Cecilia Barese, MDPhD, Connie Trimble, MD, Michael Keller, MD, Ephraim J. Fuchs, MD MBA, Catherine M. Bollard, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 1923.
https://doi.org/10.1182/blood.V130.Suppl_1.1923.1923
Published: 2017
Journal Articles

Complete Remissions Post Infusion of Multiple Tumor Antigen Specific T Cells for the Treatment of High Risk Leukemia and Lymphoma Patients after HCT

Kirsten M. Williams, MD, Patrick Hanley, PhD, Melanie Grant, PhD, Maria Fernanda Fortiz, BA, Maja Stanojevic, MD, Mimi Ismail, BA, Fahmida Hoq, MD, Maria Martin Manso, PhD, Jamie Hoover, Robert Ulrey, BA, Ella Kathy Mintz, MS, Anna Namata, BS, Elizabeth Williams, Shuroug Albihani, Michael Keller, MD, Conrad Russell Young Cruz, MD PhD, Haili Lang, Austin John Barrett, MD FRCP, FRCPath, Stephen Gottschalk, MD, Hao Liu, Shannon R. McCurdy, MD, Richard J. Jones, MD, Catherine M. Bollard, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 4516.
https://doi.org/10.1182/blood.V130.Suppl_1.4516.4516
Published: 2017
Journal Articles

Cytotoxic T Lymphocytes (CTL) Specific for CMV, Adenovirus, and EBV Can Be Generated From Naive T Cells for Adoptive Immunotherapy.

Patrick Hanley, Barbara Savoldo, MD, PhD, Conrad Russell Young Cruz, MD, Ann M. Leen, PhD, Jeffrey J. Molldrem, M.D., Hao Liu, Adrian P. Gee, PhD, Helen E. Heslop, MD, Gianpietro Dotti, MD, John Rodgers, PhD, Cliona M Rooney, PhD, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath, Elizabeth J. Shpall, MD, Catherine M. Bollard, MD, FRACP, FRCPA
Journal: Blood
Blood (2009) 114 (22): 504.
https://doi.org/10.1182/blood.V114.22.504.504
Published: 2009
Journal Articles

Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes

Patrick J. Hanley, Conrad Russell Young Cruz, Barbara Savoldo, Ann M. Leen, Maja Stanojevic, Mariam Khalil, William Decker, Jeffrey J. Molldrem, Hao Liu, Adrian P. Gee, Cliona M. Rooney, Helen E. Heslop, Gianpietro Dotti, Malcolm K. Brenner, Elizabeth J. Shpall, Catherine M. Bollard
Journal: Blood
Blood (2009) 114 (9): 1958–1967.
https://doi.org/10.1182/blood-2009-03-213256
Published: 2009